Vice President Intellectual Property @ (February 2023 - April 2026)
Vice President Intellectual Property @ (June 2019 - February 2023)
Fee Earner, Life Sciences Practice Group @ (October 2017 - May 2019)
Principal Patent Counsel - Biology @ (January 2015 - September 2017)
Guest Lecturer @ (October 2014 - November 2015)
Patent Attorney @ (January 2012 - January 2015)
Director of pre-clinical research @ (April 2010 - January 2012)
Postdoctoral fellow @ (August 2009 - April 2010)
Eli Gilsohn Education
The College of Management Academic Studies
MBA (Biomedical management)
2010-2012
Weizmann Institute of Science
Ph.D. (Developmental Genetics)
2005-2009
Weizmann Institute of Science
M.Sc. (Biology of The Cell)
2003-2005
Tel Aviv University
B.Sc. (Biology)
1999-2002
Eli Gilsohn Skills
Patent Prosecution
Intellectual Property
Patents
Patentability
Drafting patent applications
Molecular Biology
Protein Chemistry
Biotechnology
Lifesciences
Cell Biology
In Vitro
R&D
Science
Tissue Culture
DNA
Research
Cell Culture
Life Sciences
Genetics
In Vivo
Cell
ELISA
Writing
Animal Models
Leading Projects
Technology Transfer
Molecular Genetics
Microscopy
Biomedical Engineering
Stem Cells
qPCR
Pre-Clinical Management
Pharmaceutical Industry
PCR
Fluorescence Microscopy
Confocal Microscopy
Pre Clinical Management
Research and Development R&d
Patent Law
Research and Development
Eli Gilsohn Summary
Eli Gilsohn, based in London, GB, is currently a VP, Intellectual Property and Technology Strategy at Resolution Therapeutics. Eli Gilsohn brings experience from previous roles at Resolution Therapeutics, Tropic Biosciences, Carpmaels & Ransford and Quark Pharmaceuticals. Eli Gilsohn holds a 2010 - 2012 MBA in Biomedical management @ The College of Management Academic Studies. With a robust skill set that includes Patent Prosecution, Intellectual Property, Patents, Patentability, Drafting patent applications and more. Eli Gilsohn has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Eli Gilsohn?
Find contact details for 700 million professionals.